Clinical-Pathological Study on Incidental Prostate Cancer in Patients Operated Under the Assumed Diagnosis of Symptomatic BPH

    January 2006 in “ Actas Urológicas Españolas ”
    E. Fernández Rosado, F. Gómez Veiga, L. Álvarez Castelo, M. Ruibal Moldes, Venancio Chantada Abal, M. González Martín
    Image of study
    TLDR Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.
    This retrospective study analyzed 1,593 patients who underwent prostate surgery for symptomatic benign prostatic hyperplasia (BPH) and found incidental prostate cancer (CPI) in 78 cases, with a prevalence of 4.89% and an incidence of 13 cases per year. The study spanned 6 years and included two surgical methods: suprapubic prostatectomy (APS) and transurethral resection of the prostate (RTU-P). The average age was 73.6 years, and the average PSA level was 6 ng/ml. Most tumors were well-differentiated and in stage pT1a. A watchful waiting approach was chosen for 57% of patients, with a 13.3% tumor progression rate and a 2.6% CPI-specific mortality over an average follow-up of 47.19 months. No significant differences in CPI prevalence were observed between the APS and RTU-P groups.
    Discuss this study in the Community →